Surgery drug may ease emotional toll of breast cancer
NCT ID NCT07367542
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving esketamine continuously during breast cancer surgery can reduce feelings of anxiety and depression after the operation. About 218 women having breast cancer surgery will be randomly assigned to receive either esketamine or a placebo during anesthesia. The main goal is to see if the drug improves emotional well-being and sleep quality in the days following surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Medical center of Chinese PLA General Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a personalized exercise program boost recovery in cancer survivors?